Stocks to Watch Tuesday: Eli Lilly, Robinhood, Trump Media, Teladoc

As we dive into another trading week, investors are keeping a close eye on several key stocks. Let's take a look at what's happening with Eli Lilly, Robinhood, Trump Media & Technology Group (TMTG), and Teladoc.



Eli Lilly (LLY) reported its Q3 2024 earnings on Oct 30, 2024, posting EPS of $1.18, which exceeded analysts' expectations by 18.62%. The company's revenue in Q3 2024 increased 20% year-over-year, driven by volume growth from Mounjaro and Zepbound, partially offset by the $1.42 billion revenue from the sale of rights for the olanzapine portfolio (Zyprexa) in Q3 2023. Excluding this divestiture activity, total revenue increased by 42%.

Eli Lilly's Q3 2024 EPS increased to $1.07 on a reported basis and $1.18 on a non-GAAP basis, both inclusive of $3.08 of acquired IPR&D charges. The company updated its 2024 revenue guidance range to $45.4 to $46.0 billion and its reported EPS guidance to the range of $12.05 to $12.55. The non-GAAP EPS guidance was updated to the range of $13.02 to $13.52, both driven by the acquired IPR&D charges incurred in Q3.




Robinhood (HOOD) reported strong user data and Deutsche Bank analysts upgraded the stock to "buy" from "hold," lifting its price target from $21 to $24. The e-brokerage had 24.2 million funded customers at the end of July, up about 70,000 from June and more than 1 million from the same period a year ago. Assets under custody (AUC) were $144.5 billion, a 3% rise from the month before and up 53% year-over-year.

Robinhood's revenue in 2023 was $1.86 billion, a 37% year-over-year increase. The stock trading app reported an annual net loss of $540 million in 2023. Robinhood had 10.8 million active users in 2022 and $89 billion assets under management at the end of the second quarter 2023.



Trump Media & Technology Group (TMTG) reported a net loss of $49 million in the first nine months of 2023. The company expects to continue operating at a loss for the foreseeable future. TMTG's stock price has been volatile, with shares trading at around $10 as of November 2024. The company faces several risks and challenges, including the high failure rate of new social media platforms, dependence on Trump's popularity and support, regulatory and legal challenges, market volatility and investor sentiment, and lack of transparency in key performance metrics.



Teladoc (TDOC) is a telemedicine company that provides remote healthcare services. The company's stock price has been volatile, with shares trading at around $10 as of November 2024. Teladoc faces several challenges, including competition from traditional healthcare providers and other telemedicine companies, regulatory hurdles, and the need to maintain its market share in the face of changing consumer preferences.



In conclusion, investors should keep a close eye on Eli Lilly, Robinhood, Trump Media & Technology Group, and Teladoc as these companies continue to navigate the ever-changing landscape of the stock market. By staying informed and making strategic decisions, investors can capitalize on opportunities and mitigate risks in their portfolios.